09-Feb-2012 - AMPAC Fine Chemicals posted a 50 per cent jump in revenues after the return of sales from its antiviral business.
08-Feb-2012 - AMRI posted a Q4 loss on lower sales but predicts that contracting revenues and margins will increase in 2012 thanks to cost cutting measures and new contracts
08-Feb-2012 - Cambrex expects fine chemical consolidation to continue this year and is being “proactive” in its hunt for takeover targets.
02-Feb-2012 - A round-up of news in the contract manufacturing space, with developments at Foster Delivery Sciences, Excella, Catalent and RohnerChem.
16-Jan-2012 - The US FDA has sent its generic user fee recommendations to Congress ahead of a meeting to discuss the plan next month.
11-Jan-2012 - Greater collaboration between regulators, suppliers and manufacturers is needed to reverse decades of supply chain neglect, an expert said.
11-Jan-2012 - Sanofi announced it will cut $170m of its operational costs this year as it plans to ramp-up acquisitions spending to $2.6bn.
10-Jan-2012 - Xoma will further reduce its manufacturing capacity with plans to cut a third of its workforce.
09-Jan-2012 - The USP has published draft supply chain integrity guidance outlining steps to stop counterfeit or adulterated drugs reaching patients.
20-Dec-2011 - DSM Biologics will work with the Australian Institute for Bioengineering and Nanotechnology (AIBN) on the commercialisation of development-stage biologics projects.
15-Dec-2011 - AMPAC posted a fourth quarter loss as process improvement difficulties offset rising demand for CNS and oncology ingredients.
14-Dec-2011 - The EMA has recommended recalling a batch of Gilead’s Vistide manufactured by Ben Venue over particle contamination concerns.
06-Dec-2011 - Samsung will set up a $300m biosimilars development JV with Massachusetts, US-based Biogen Idec, building on the partnership it forged with CRO Quintiles earlier this year.
01-Dec-2011 - Biologics Modular is leasing its mobile production facilities to help clients make FDA regulated drugs without fixed plants.
28-Nov-2011 - Industry reluctance to share information on economic adulteration is hindering FDA efforts to tackle tainted ingredients, a GAO report found.
23-Nov-2011 - The EMA is recalling cancer drugs manufactured by CMO Ben Venue Laboratories after inspectors found quality shortcomings.
21-Nov-2011 - Ben Venue Laboratories has voluntarily suspended manufacture at the Ohio plant linked to drug shortages.
15-Nov-2011 - Wholesalers’ trust in the quality of products from some countries could decrease vigilance and allow counterfeits to reach pharmacies, research found.
15-Nov-2011 - To boost solubility pharma must develop, refine and improve existing methods as a “quantum leap” in formulation is unlikely, Pharmaterials' CEO said.
09-Nov-2011 - The EMA plans to update guidance on certification and batch release in response to globalisation of the pharma supply chain.
03-Nov-2011 - Bend Research is developing a nanoparticle drug delivery system for treating osteoarthritis in a “close collaboration” with Pfizer.
02-Nov-2011 - SurModics is selling its drug delivery assets and cGMP manufacturing facility to Evonik for $30m (€22m) in cash.
31-Oct-2011 - In-PharmaTechnologist presents a roundup of news and views shared by exhibitors and attendees at AAPS and CPhI.
19-Oct-2011 - Canadian pharma manufacturers’ plan to stop drug shortages by sharing information fails to tackle underlying concerns, an analyst said.
10-Oct-2011 - Akorn is doubling capacity and hiring “as fast as [it] can” after drug shortages sent demand for its injectables soaring.